Integrative Analysis of Somatic Mutations Altering MicroRNA Targeting in Cancer Genomes

Determining the functional impact of somatic mutations is crucial to understanding tumorigenesis and metastasis. Recent sequences of several cancers have provided comprehensive lists of somatic mutations across entire genomes, enabling investigation of the functional impact of somatic mutations in non-coding regions. Here, we study somatic mutations in 3′UTRs of genes that have been identified in four cancers and computationally predict how they may alter miRNA targeting, potentially resulting in dysregulation of the expression of the genes harboring these mutations. We find that somatic mutations create or disrupt putative miRNA target sites in the 3′UTRs of many genes, including several genes, such as MITF, EPHA3, TAL1, SCG3, and GSDMA, which have been previously associated with cancer. We also integrate the somatic mutations with germline mutations and results of association studies. Specifically, we identify putative miRNA target sites in the 3′UTRs of BMPR1B, KLK3, and SPRY4 that are disrupted by both somatic and germline mutations and, also, are in linkage disequilibrium blocks with high scoring markers from cancer association studies. The somatic mutation in BMPR1B is located in a target site of miR-125b; germline mutations in this target site have previously been both shown to disrupt regulation of BMPR1B by miR-125b and linked with cancer.

[1]  Anupama E. Gururaj,et al.  Correction for Gururaj et al., MTA1, a transcriptional activator of breast cancer amplified sequence 3 , 2006, Proceedings of the National Academy of Sciences.

[2]  Yan Cui,et al.  PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits , 2011, Nucleic Acids Res..

[3]  J. Schachter,et al.  Mutagen-Specific Mutation Signature Determines Global microRNA Binding , 2011, PloS one.

[4]  J. Moult,et al.  Structural and functional impact of cancer-related missense somatic mutations. , 2011, Journal of molecular biology.

[5]  Kris Richardson,et al.  A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS , 2011, BMC Genomics.

[6]  Dongsheng Yu,et al.  Molecular Characterization of the MicroRNA-138-Fos-like Antigen 1 (FOSL1) Regulatory Module in Squamous Cell Carcinoma* , 2011, The Journal of Biological Chemistry.

[7]  L. Fan,et al.  Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility , 2011, PLoS genetics.

[8]  Peifang Liu,et al.  Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification , 2011, Proceedings of the National Academy of Sciences.

[9]  D. Bartel,et al.  Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.

[10]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[11]  William C. Hahn,et al.  Towards systematic functional characterization of cancer genomes , 2011, Nature Reviews Genetics.

[12]  Laurent F. Thomas,et al.  Inferring causative variants in microRNA target sites , 2011, Nucleic acids research.

[13]  M. Carmo-Fonseca,et al.  TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells , 2011, Leukemia.

[14]  Peter Kraft,et al.  Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. , 2011, Carcinogenesis.

[15]  Wei Zhang,et al.  A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China , 2011, Molecular Biology Reports.

[16]  Florian Buettner,et al.  The sufficient minimal set of miRNA seed types , 2011, Bioinform..

[17]  M. Stratton Exploring the Genomes of Cancer Cells: Progress and Promise , 2011, Science.

[18]  L. Chin,et al.  Making sense of cancer genomic data. , 2011, Genes & development.

[19]  S. Bru,et al.  Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3 Genes That Are Both Downregulated in Expression in Breast and Prostate Cancers , 2011, PloS one.

[20]  Jannik N. Andersen,et al.  Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.

[21]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[22]  Richard Simon,et al.  Identifying cancer driver genes in tumor genome sequencing studies , 2011, Bioinform..

[23]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[24]  S. Ariyan,et al.  A Variant in a MicroRNA Complementary Site in the 3′UTR of the KIT Oncogene Increases Risk of Acral Melanoma , 2010, Oncogene.

[25]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[26]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[27]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[28]  B. Zhang,et al.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 , 2011, Nature Genetics.

[29]  Li Ding,et al.  Complete characterization of the microRNAome in a patient with acute myeloid leukemia. , 2010, Blood.

[30]  G. Tsujimoto,et al.  MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)* , 2010, The Journal of Biological Chemistry.

[31]  B. Necela,et al.  Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype , 2010, PloS one.

[32]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[33]  Molly Hammell,et al.  Computational methods to identify miRNA targets. , 2010, Seminars in cell & developmental biology.

[34]  B. Berger,et al.  Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3′UTRs , 2010, Proceedings of the National Academy of Sciences.

[35]  Takaya Saito,et al.  MicroRNAs--targeting and target prediction. , 2010, New biotechnology.

[36]  Deborah Hughes,et al.  Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer , 2010, Nature Genetics.

[37]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[38]  A. Sparks,et al.  The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.

[39]  Scott B. Dewell,et al.  Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.

[40]  Jun Yu,et al.  Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. , 2010, Carcinogenesis.

[41]  M. Björkholm,et al.  The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. , 2010, Gastroenterology.

[42]  E. Birney,et al.  A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.

[43]  Tom Royce,et al.  A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.

[44]  Daniel J. Blankenberg,et al.  Galaxy: A Web‐Based Genome Analysis Tool for Experimentalists , 2010, Current protocols in molecular biology.

[45]  Eckart Meese,et al.  High-throughput miRNA profiling of human melanoma blood samples , 2010, BMC Cancer.

[46]  D. Jukic,et al.  Microrna profiling analysis of differences between the melanoma of young adults and older adults , 2010, Journal of Translational Medicine.

[47]  Fabian J Theis,et al.  PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes , 2010, Genome Biology.

[48]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[49]  Martin Reczko,et al.  Lost in translation: an assessment and perspective for computational microRNA target identification , 2009, Bioinform..

[50]  David Smith,et al.  A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. , 2009, Cancer research.

[51]  A. Mele,et al.  Ago HITS-CLIP decodes miRNA-mRNA interaction maps , 2009, Nature.

[52]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[53]  Deborah Hughes,et al.  A genome-wide association study of testicular germ cell tumor , 2009, Nature Genetics.

[54]  R. Yantiss,et al.  Clinical, Pathologic, and Molecular Features of Early-onset Colorectal Carcinoma , 2009, The American journal of surgical pathology.

[55]  K. Ogawa,et al.  Distinctive expression and function of four GSDM family genes (GSDMA‐D) in normal and malignant upper gastrointestinal epithelium , 2009, Genes, chromosomes & cancer.

[56]  M. D. Boer,et al.  Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia , 2009, Leukemia.

[57]  J. Coulson,et al.  SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer , 2009, Clinical Cancer Research.

[58]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[59]  Praveen Sethupathy,et al.  MicroRNA target site polymorphisms and human disease. , 2008, Trends in genetics : TIG.

[60]  Kishore Guda,et al.  The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.

[61]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[62]  Frank J. Slack,et al.  MicroRNAs and cancer: An overview , 2008, Cell cycle.

[63]  M. Copetti,et al.  Molecular Detection of Neuron-Specific ELAV-Like-Positive Cells in the Peripheral Blood of Patients with Small-Cell Lung Cancer , 2008, Cellular Oncology.

[64]  Wei Zhang,et al.  Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. , 2008, Carcinogenesis.

[65]  Joe W. Gray,et al.  Translating insights from the cancer genome into clinical practice , 2008, Nature.

[66]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[67]  S. Robinson,et al.  MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. , 2008, Cancer research.

[68]  R. Place,et al.  MicroRNA-373 induces expression of genes with complementary promoter sequences , 2008, Proceedings of the National Academy of Sciences.

[69]  A. Mahadevan,et al.  Human BCAS3 Expression in Embryonic Stem Cells and Vascular Precursors Suggests a Role in Human Embryogenesis and Tumor Angiogenesis , 2007, PLoS ONE.

[70]  K. Ogawa,et al.  GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-β-dependent apoptotic signalling , 2007, Oncogene.

[71]  K. Sirotkin,et al.  The NCBI dbGaP database of genotypes and phenotypes , 2007, Nature Genetics.

[72]  R. Lotan,et al.  Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis , 2007, Clinical Cancer Research.

[73]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[74]  J. Steitz,et al.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.

[75]  David P. Bartel,et al.  Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .

[76]  Wen-Hsiung Li,et al.  Human polymorphism at microRNAs and microRNA target sites , 2007, Proceedings of the National Academy of Sciences.

[77]  David Haussler,et al.  The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..

[78]  Ligang Wu,et al.  PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits , 2006, Nucleic Acids Res..

[79]  A. Hatzigeorgiou,et al.  A guide through present computational approaches for the identification of mammalian microRNA targets , 2006, Nature Methods.

[80]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[81]  C. Tabone,et al.  Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines. , 2006, Biochemical and biophysical research communications.

[82]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[83]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[84]  Yuriy Gusev,et al.  Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.

[85]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[86]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[87]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[88]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[89]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[90]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[91]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..